Funding

SECTION I: ESTIMATION OF COSTS

 

1 Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result.
 … in terms of IPR protectionThe full cost for securing the patent and renewing it for 5 years is 1450 €.…in terms of product developmentFor the product development 5 employees are need for a period of maximum 4 months. With a salary of 2000€ each this will cost about 40.000€. In this cost the translation of the software in Greek is included.…in terms of mass production

Touch Screens  100 €  (using a filter that makes the a normal screen touch screen)

Lego Robots  200  €

Software licenses for educational material  100 €

Stress watches 1000 €

RFID readers and tags 150  €

Toys 50 €

3 employees working on a full time basis with a salary of 2000 €

Consultation services from a doctor, a pedopsychologist and an educator 3000  €

… in terms of marketing

The marketing costs for the product are estimated at about 15.000 € for the first year.

 

2 Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs 
  Year 1 Year 2 Year 3 Year 4 Year 5
Fixed costs 640.000 1.280.000 1.600.000 1.920.000 2.400.000
Personnel 88.000 72.000 72.000 72.000 72.000
Other running costs 3000        
Marketing costs 15.000 10.000 10.000 10.000 10.000
TOTAL EXPECTED COSTS 746.000 1.352.000 1.682.000 2.002.000 2.482.000
Price per Unit 2000 2000 2000 2000 2000
Type of Unit  
Number of Units 400 800 1000 1200 1500
TOTAL Expected Revenues 800.000 1.600.000 2.000.000 2.400.000 3.000.000
CASH FLOW REQUIRED (REVENUES-COSTS) 54.000 248.000 318.000 398.000 518.000
TOTAL CAPITAL required for five years 8.264.000
             

 

SECTION 2: QUALITATIVE FACTORS

 

3 Dimension of identified target groups
 The goal of NOESIS should be to be distributed in all the English speaking markets and Greece. By using an intense advertising campaign in the US, Canada, UK, Australia and Greece, NOESIS can easily achieve the break even point of sales and start making profits. The goal is to sell in these markets 400 units for the first year and 800 for the second year.

 

4 Evaluation of financial Risks for R&D result
 The financial risks attached to the development of NOESIS are small, since there is already active demand for the product, the R&D Result has been tested, the development costs are small and there is a technical team ready to produce it. The lack same products in the market is also very important.

 

 SECTION 3: IDENTIFICATION OF FINANCING SOURCES

 

After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)

 1. European FundingDefine relevance of the product with the following potential funding sources and comment
 

 

 

  • At regional level, the JEREMIE initiative  provides financing from seed capital funds and other types of investors.

 

 

 

2. National Funding
 National Innovation Programs, for example National Strategic Reference Framework (ESPA) could be used for development and marketing costs. 

 

3. Private funding
 Private funding sources are investors using their own funds and capital borrowed from banks. 

  

 

SECTION 3: FINAL EVALUATION

 

It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)…

Taking under consideration the funding opportunities for NOESIS, the most suitable method for product deployment would be the creation of a new commercial firm. 

This new firm can be funded by an investor or a group of investors, who will combine private capital with european funding opportunities in order to organise mass production and promote the product in all the possible markets mentioned earlier.

The team that created NOESIS should be used as the expertise staff in charge of product development, production and technical support.

 

  

Decision of evaluation

  • The R&D has a high potential of exploitation 
Bookmark the permalink. Follow any comments here with the RSS feed for this post. Post a comment or leave a trackback: Trackback URL.

Post a Comment

You must be logged in to post a comment.

Request a proposal

Valorisation Plan Authors

Visit the other applications of the INTERVALUE Platform: R&D Repository | IP Agreements

© 2009-2010 INTERVALUE Project